Annual report pursuant to Section 13 and 15(d)

Noncontrolling Interest

v3.22.1
Noncontrolling Interest
12 Months Ended
Dec. 31, 2021
Noncontrolling Interest [Abstract]  
NONCONTROLLING INTEREST

NOTE 13 – NONCONTROLLING INTEREST

 

As of December 31, 2021, Dr. Yu Zhou, former director and former co-chief executive officer of Genexosome, who owns 40% of the equity interests of Genexosome, which is not under the Company’s control.

 

During the years ended December 31, 2021 and 2020, the Company did not allocate any net loss and foreign currency translation adjustment to the noncontrolling interest holder due to its inability to satisfy these deficits.